Viltolarsen Earns European Orphan Drug Designation as DMD Treatment
News
The European Commission has granted orphan drug designation to viltolarsen, a treatment for people with Duchenne muscular dystrophy (DMD) amenable to exon 53 skipping, Nippon Shinyaku announced in a press release. The ... Read more